Details of issuance or disposal
Completion of the exercise of the 21st Series of Stock Acquisition Rights through a private placement
86,839,792 shares
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
Amount from issuance of stock acquisition rights: ¥3,448,280; amount from exercise of stock acquisition rights: ¥1,540,742,891; total funds raised: ¥1,544,191,171
| Item | Details |
|---|---|
| Type of issuance or disposal | Completion of the exercise of the 21st Series of Stock Acquisition Rights through a private placement |
| Number of shares to be issued or disposed of | 86,839,792 shares |
| Amount of funds to be raised | Amount from issuance of stock acquisition rights: ¥3,448,280; amount from exercise of stock acquisition rights: ¥1,540,742,891; total funds raised: ¥1,544,191,171 |
| Intended allottee | Name Ogawa Kohei (小川浩平) / Number of stock acquisition rights 637,932 stock acquisition rights / Potential shares 63,793,200 potential shares, Name Odaka Koji (小高功嗣) / Number of stock acquisition rights 51,724 stock acquisition rights / Potential shares 5,172,400 potential shares |
| Exercise price | Initial exercise price: ¥29; revised exercise price: ¥21 from 24 June 2025 to 10 December 2025, and ¥9.9 from 11 December 2025 onward. Details of the adjustment provisions and the floor price: not disclosed |
| Exercise period | From 17 December 2024 to 16 December 2026 |
| Number of Stock Acquisition Rights | Total number issued: 689,656 stock acquisition rights; unexercised balance: 0 |
| Most recent equity financing | 21st Series of Stock Acquisition Rights approved on 29 November 2024, with payment made on 16 December 2024. The document states a total issue price of ¥3,448,280 and proceeds of ¥2,000,002,400 from exercise |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The exercise of the 21st Series of Stock Acquisition Rights was completed. The document provides no specific explanation of the use of proceeds or the background to completion of the exercise.